Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).

	Amgen	Gilead Sciences	Biogen	Seattle Genetics	NOVOZYMES A/S/S
Symbol	NASDAQ:AMGN	NASDAQ:GILD	NASDAQ:BIIB	NASDAQ:SGEN	OTCMKTS:NVZMY
Price Information
Current Price	$195.47	$66.52	$236.63	$70.63	$43.23
52 Week Range	Buy	Buy	Hold	Buy	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Hold	Buy	Buy
Consensus Price Target	$216.9375	$82.90	$270.00	$85.2727	N/A
% Upside from Price Target	10.98% upside	24.62% upside	14.10% upside	20.73% upside	N/A
Trade Information
Market Cap	$117.45 billion	$86.22 billion	$43.52 billion	$11.46 billion	$13.15 billion
Beta	1.11	1.1	1.01	1.97	0.76
Average Volume	2,807,158	5,714,033	1,182,310	584,876	22,548
Sales & Book Value
Annual Revenue	$23.75 billion	$22.13 billion	$13.45 billion	$654.70 million	$2.28 billion
Price / Sales	4.94	3.81	3.24	17.45	5.63
Cashflow	$18.0489 per share	$7.1604 per share	$31.8479 per share	N/A	$1.6801 per share
Price / Cash	10.83	9.29	7.43	N/A	25.73
Book Value	$19.62 per share	$16.65 per share	$64.68 per share	$7.95 per share	$6.10 per share
Price / Book	9.96	4.00	3.66	8.88	7.09
Profitability
Net Income	$8.39 billion	$5.46 billion	$4.43 billion	$-222,690,000.00	$511 million
EPS	$14.40	$6.15	$26.20	($1.65)	$1.75
Trailing P/E Ratio	13.57	10.82	9.03	N/A	24.70
Forward P/E Ratio	12.68	9.75	7.35	N/A	24.70
P/E Growth	$2.29	$3.23	$0.87	N/A	$2.10
Net Margins	33.78%	26.64%	37.62%	-36.94%	22.31%
Return on Equity (ROE)	76.17%	37.12%	44.89%	-17.16%	28.26%
Return on Assets (ROA)	14.36%	13.06%	23.23%	-14.39%	15.95%
Dividend
Annual Payout	$5.80	$2.52	N/A	N/A	$0.50
Dividend Yield	2.97%	3.79%	N/A	N/A	1.16%
Three-Year Dividend Growth	18.70%	20.90%	N/A	N/A	N/A
Payout Ratio	40.28%	40.98%	N/A	N/A	28.57%
Years of Consecutive Dividend Growth	8 Years	3 Years	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	2.58%	1.13%	0.49%	N/A	0.05%
Current Ratio	2.89%	3.76%	2.46%	3.03%	1.22%
Quick Ratio	2.60%	3.67%	2.22%	2.70%	0.71%
Ownership Information
Institutional Ownership Percentage	76.28%	79.89%	86.55%	99.14%	0.18%
Insider Ownership Percentage	0.25%	0.20%	0.39%	33.80%	N/A
Miscellaneous
Employees	21,500	11,000	7,800	1,302	6,427
Shares Outstanding	599.70 million	1.27 billion	184.45 million	161.72 million	297.00 million
Next Earnings Date	10/29/2019 (Estimated)	10/24/2019 (Estimated)	10/22/2019 (Estimated)	10/24/2019 (Estimated)	10/23/2019 (Estimated)
Optionable	Optionable	Optionable	Optionable	Optionable	Not Optionable
	Amgen	Gilead Sciences	Biogen	Seattle Genetics	NOVOZYMES A/S/S

Comparison Ideas: